Friday, 17 Aug 2018

You are here

Dr. Olga Petryna - Canakinumab in CVD Pts Prevents Acute Gout Attacks

Dr. Petryna reviews Dr. Dan Solomon's EULAR 2018 plenary presentation showing a 50-60% reduction in acute gout amongst CVD patients treated with canakinumab.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Cassie Calabrese: Immune-related...

14 Jun 2017

Dr. Bernie Rubin: Fellows Program at...

09 Feb 2018

The RheumNow Week in Review – 28...

28 Oct 2016

Dr. Janet Pope: Gout Gamechangers

07 Nov 2017

Dr. Janet Pope: JAK 2 Inhibitor...

07 Nov 2017

The RheumNow Week in Review – No Good...

10 Aug 2018

Dr. Janet Pope: Pre-op for Total Hip or...

07 Nov 2017

8 September 2017: The RheumNow Week in...

07 Sep 2017

Dr. Rachel T. Huston: Cardiovascular...

08 Dec 2016

The RheumNow Week in Review - 26...

26 Jan 2018

Dr. Olga Petryna: Cardiovascular risk...

12 Jun 2017

Alvin Wells, MD: JAK Inhibitors, Other...

08 Nov 2015